Experiences with Adverse Drug Reaction Reporting by Patients An 11-Country Survey
作者： Florence van Hunsel , Linda Härmark , Shanthi Pal , Sten Olsson , Kees van Grootheest
DOI: 10.2165/11594320-000000000-00000
关键词:
摘要: Background: Patients are important stakeholders in pharmacovigilance; however, little formal evaluation has been undertaken of existing patient reporting schemes within and outside Europe. If is to be recognized as beneficial for pharmacovigilance further optimized, methodology best practice must internationally shared promoted.
springer.com
who-umc.org
sci-hub.se 参考文章(38)
R. Watson, New rules will allow EU patients to report drug concerns directly BMJ. ,vol. 341, ,(2010) , 10.1136/BMJ.C5344
Christian Frankenfeld, “Serious” and “severe” adverse drug reactions need defining BMJ. ,vol. 329, pp. 573.1- 573 ,(2004) , 10.1136/BMJ.329.7465.573
Elliot G. Brown, Louise Wood, Sue Wood, The medical dictionary for regulatory activities (MedDRA). Drug Safety. ,vol. 20, pp. 109- 117 ,(1999) , 10.2165/00002018-199920020-00002
Sten Olsson, Shanthi N. Pal, Andy Stergachis, Mary Couper, Pharmacovigilance activities in 55 low- and middle-income countries: a questionnaire-based analysis. Drug Safety. ,vol. 33, pp. 689- 703 ,(2010) , 10.2165/11536390-000000000-00000
Florence van Hunsel, Eugène van Puijenbroek, Lolkje de Jong- van den Berg, Kees van Grootheest, Media attention and the influence on the reporting odds ratio in disproportionality analysis: an example of patient reporting of statins Pharmacoepidemiology and Drug Safety. ,vol. 19, pp. 26- 32 ,(2010) , 10.1002/PDS.1865
Claire Anderson, Alison Gifford, Anthony Avery, Heather Fortnum, Elizabeth Murphy, Janet Krska, Christine Bond, , Assessing the usability of methods of public reporting of adverse drug reactions to the UK Yellow Card Scheme. Health Expectations. ,vol. 15, pp. 433- 440 ,(2012) , 10.1111/J.1369-7625.2011.00686.X
K. Jansson, Y. Ekbom, G. Sj??lin-Forsberg, ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006 Drug Safety. ,vol. 29, pp. 911- 1010 ,(2006) , 10.2165/00002018-200629100-00035
Kees van Grootheest, Lolkje de Jong-van den Berg, Patients' role in reporting adverse drug reactions. Expert Opinion on Drug Safety. ,vol. 3, pp. 363- 368 ,(2004) , 10.1517/14740338.3.4.363
Joyce de Langen, Florence van Hunsel, Anneke Passier, Lolkje de Jong-van den Berg, Kees van Grootheest, Adverse drug reaction reporting by patients in the Netherlands: three years of experience. Drug Safety. ,vol. 31, pp. 515- 524 ,(2008) , 10.2165/00002018-200831060-00006
Florence van Hunsel, Christine van der Welle, Anneke Passier, Eugène van Puijenbroek, Kees van Grootheest, Motives for reporting adverse drug reactions by patient-reporters in the Netherlands European Journal of Clinical Pharmacology. ,vol. 66, pp. 1143- 1150 ,(2010) , 10.1007/S00228-010-0865-7